Home/Filings/4/0001724311-25-000011
4//SEC Filing

Schuth Alexander O. 4

Accession 0001724311-25-000011

CIK 0001714899other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 8:33 PM ET

Size

6.4 KB

Accession

0001724311-25-000011

Insider Transaction Report

Form 4
Period: 2025-08-12
Schuth Alexander O.
COFO and Secretary
Transactions
  • Sale

    Common Stock

    2025-08-12$13.58/sh2,937$39,884242,346 total
Holdings
  • Common Stock

    (indirect: See footnote)
    523,749
Footnotes (5)
  • [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
  • [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.35 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F3]Includes 128,405 Unvested RSUs.
  • [F4]Includes 975 shares acquired under the ESPP Purchase on June 2, 2025.
  • [F5]The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Issuer

Denali Therapeutics Inc.

CIK 0001714899

Entity typeother

Related Parties

1
  • filerCIK 0001724311

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:33 PM ET
Size
6.4 KB